USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PHOTOSWITCH BIOSCIENCES, INC.
Address:
1600 ADAMS DR
MENLO PARK, CA 94025
EIN:
352339215
DUNS:
827056362
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,059,441.00 3
SBIR Phase II $1,200,000.00 1

Award List:

Ion Channel Drug Discovery Using Photoswitch Technology

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$334,910.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Ion channels are membrane proteins that allow the selective movement of charged molecules through cellular membranes. Many disease states, such as cystic fibrosis, muscular dystrophies, hypertension, and cardiac arrhyth mias are caused by ion channel pathologies.… More

Vision restoration with photoswitch technology

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$374,532.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Retinitis Pigmentosa (RP) is an inherited disease of the eye that robs its victims of vision. The loss of vision is caused by the degeneration of the rods and cones of the retina while other cells in the retina remain alive. RD is a relatively rare disease,… More

Pharmaceutical Therapy for Seasonal Affective Disorder

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$349,999.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Seasonal Affective Disorder (SAD) is one of the most common mood disorders, affecting 1-3% of the population in temperate climates, predominantly women. Currently, there are no specific drug therapies for SAD. Patients are prescribed general anti-depressants or… More

Ion Channel Drug Discovery Using Photoswitch Technology

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,200,000.00
Agency:
HHS
Principal Investigator:
Andrew Blatz – 650-773-2942
Abstract:
DESCRIPTION (provided by applicant): Ion channels are membrane proteins that allow the selective movement of charged molecules through cellular membranes. Many disease states, such as cystic fibrosis, muscular dystrophies, hypertension, and cardiac arrhythmias are caused by ion channel pathologies.… More